BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7491579)

  • 21. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated hemolytic uremic syndrome.
    Hrozencik SP; Connaughton MJ
    Oncol Nurs Forum; 1988; 15(6):755-9. PubMed ID: 3205834
    [No Abstract]   [Full Text] [Related]  

  • 23. Mitomycin C associated hemolytic uremic syndrome.
    Jain S; Seymour AE
    Pathology; 1987 Jan; 19(1):58-61. PubMed ID: 3108839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
    Wils J; Grave W; van Breda Vriesman PJ
    Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
    [No Abstract]   [Full Text] [Related]  

  • 27. [Female with breast cancer, undergoing chemotherapeutic treatment hospitalized because of general deterioration, anemia and renal insufficiency].
    Rev Clin Esp; 1990 Jun; 187(2):82-8. PubMed ID: 2123041
    [No Abstract]   [Full Text] [Related]  

  • 28. Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
    van Spreeuwel JP; Hemrika MH; de Maat CE; Nadorp JH
    Neth J Med; 1983; 26(9):287-8. PubMed ID: 6419134
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Anai H; Okada Y; Okubo K; Korenaga D; Maehara Y; Sugimachi K; Ohi Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1487-91. PubMed ID: 2120375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 33. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
    Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
    Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome.
    Kluger NJ; Cummings FJ; Ready NE; Sweeney JD; Weitberg AB
    Med Health R I; 1998 Jul; 81(7):235-6. PubMed ID: 9689787
    [No Abstract]   [Full Text] [Related]  

  • 37. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
    Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer].
    Manziuk LV; Artamonova EV; Sholokhov VN; Strygina EA
    Vopr Onkol; 2001; 47(6):736-9. PubMed ID: 11826500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.